新抗原市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00021781
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 151
Buy Now

2023年新抗原市场价值为2,71,428,570美元,预计到2028年将达到10,54,783,540美元;预计2023年至2028年复合年增长率为31.2%。

新抗原是最近开发的抗原,历史上免疫系统从未检测到过。肿瘤蛋白的改变可能导致由突变或病毒蛋白引起的新抗原的产生。新抗原用于选择性治疗癌细胞。
新抗原市场根据治疗、治疗专业和地理位置进行细分。根据地理位置,市场分为北美、欧洲、亚太地区、中东和非洲。非洲、南美洲和中美洲。该报告提供了对新抗原市场的见解和深入分析,重点关注各种参数,例如市场趋势、技术进步、市场动态以及全球领先市场参与者的竞争格局分析。它还包括所有地区的 COVID-19 影响分析。预计市场在预测期内可能会保持稳定增长。

新抗原市场利润丰厚的区域

市场洞察

新抗原疫苗的发展癌症

生物技术的发展提高了人们对免疫疗法的接受度,进一步推动了其在个性化医疗中的应用。免疫疗法广泛用于治疗癌症;一些免疫治疗程序涉及使用新抗原,即癌细胞表面存在的抗原。因此,新抗原的应用正在被广泛研究以治疗癌症。新抗原的独特性使研究人员能够识别患者的抗原。免疫系统并在不干扰健康细胞的情况下找到针对癌细胞的抗原。
2015 年进行了首次新抗原疫苗的临床试验后,免疫疗法的发展跟上了步伐。 2017 年,Neon Therapeutics 发表了另外两项临床试验研究,证明了新抗原疫苗治疗人类黑色素瘤(皮肤癌)的功效。临床试验的积极结果吸引了各种初创公司来发现和开发基于新抗原的癌症疗法。许多公司对新抗原的开发表现出了兴趣。以下是参与新抗原开发的一些公司的例子。

  • BioNTech SE 是一家从事新抗原疫苗市场业务的德国公司。 BioNTech SE 开发了个体化抗癌疫苗 (IVAC) Mutanome 平台,该平台可以改造 RNA 分子以生产定制的新抗原疫苗。针对三阴性乳腺癌、多种肿瘤类型和黑色素瘤的 IVAC 临床试验正在进行中。
  • Genocea Biosciences 的 ATLAS 平台采用离体方法开发新抗原疫苗。 Genocea Biosciences 已从 Polaris Partners、葛兰素史克和强生等投资者处筹集了约 9100 万美元资金。约翰逊创新公司开发新抗原癌症疫苗——GEN-009。目前该疫苗正处于 1a/2 期临床试验阶段,旨在治疗黑色素瘤、肺癌和癌症。
  • Gritstone Oncology 利用其 AI 平台 – EDGE – 使用一种in 技术开发新抗原疫苗-silico方法。公司已开发出两种产品GRANITE-001和SLATE-001。 GRANITE-001 被设计为基于患者特定肿瘤类型的个体化治疗,而 SLATE-001 被配制为通用新抗原疫苗,可用于多个表现出相似新抗原的患者。
  • Agenus Inc.已开发出 AutoSynVax (ASV) 新抗原疫苗,与佐剂 QS-21 Stimulon 一起施用以治疗实体瘤。目前ASV在美国正在进行一期临床试验。
  • 自2016年起,Moderna, Inc.就参与了其个性化癌症疫苗(PCV)mRNA-4157与默克公司Keytruda联合的临床试验。 2020 年 11 月,Moderna, Inc. 发布了有关其癌症疫苗的更新,指出 mRNA-4157 与 Keytruda 联合用药在所有剂量水平下均具有良好的耐受性,并且已在患者中产生了反应。

这样抗癌新抗原疫苗的发展正在推动市场增长。

基于治疗的见解

根据治疗,新抗原市场细分为联合疗法和单一疗法。到 2023 年,联合疗法预计将占据更大的市场份额。然而,单一疗法领域预计在预测期内将有更快的增长。

全球新抗原市场,按治疗分类 - 2020年及2020年2028

基于治疗专业的见解

基于治疗专业,新抗原市场细分为胃肠癌、肺癌、实体瘤、泌尿系统肿瘤癌症、黑色素瘤、头颈癌等。预计到 2023 年,胃肠道癌症领域将占据最大的市场份额,并预计在未来几年以最快的速度增长。

战略见解< /p>

市场参与者高度采用无机策略来满足不断变化的客户需求并保持改进的服务。例如,由于使用 ATLAS 平台进行新抗原识别的好处,Genocea 于 2021 年 1 月宣布发布癌症发现出版物。这一发现从理论上确保新抗原免疫疗法能够靶向正确的新抗原,同时去除抑制素,从而增强了新抗原免疫疗法的效果。

通过治疗

  • 联合疗法

    • li>
    • 单一疗法

    按治疗专业划分

    • 胃肠癌
    • 肺癌
    • 实体瘤肿瘤
    • 泌尿系统癌症
    • 黑色素瘤
    • 头颈癌
    • 其他

    作者地理位置

    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 法国
      • 德国
      • 意大利
      • 英国
      • 西班牙
      • 其他地区欧洲
    • 亚太地区 (APAC)
      • 中国
      • 印度
      • 韩国
      • < li>日本
      • 澳大利亚
      • 亚太地区其他地区
    • 中东和非洲非洲 (MEA)
      • 南非
      • 沙特阿拉伯
      • 阿联酋
      • 中东和非洲其他地区
    • 南美洲和中美洲 (SCAM)
      • 巴西
      • 阿根廷
      • 其他 SCAM
  • ul>

    公司简介

    • Achilles Therapeutics plc
    • Advaxis, Inc.
    • Frame Cancer Therapeutics
    • Genocea,Gradalis,Inc.
    • Gritstone Oncology
    • Immunicum AB
    • Medigene AG
    • Ziopharm Oncology,公司
    • 摩德纳公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is are Neoantigens?

Neoantigens are recently developed antigens that have not been detected by the immune system historically. Alterations in tumor proteins may result in the development of neoantigens caused by mutations or viral proteins. Neoantigens are used in selective treatments for cancerous cells.

What are the driving factors for the neoantigens market across the globe?

Key factors that are driving growth of the market are developments in neoantigen vaccines against cancer and increasing prevalence of cancer. However, possible side effects associated with neoantigen vaccines are likely to hinder the growth of the neoantigens market.

How many neoantigens are commercialized?

Several companies into clinical trial phases for their respective neoantigens. It is expected that by 2023, companies will commercialize their products in the market. In addition, it is expected that the cost of neoantigens will be much higher than cancer vaccines.

The List of Companies - Neoantigens Market

  1. Achilles Therapeutics plc
  2. Advaxis, Inc.
  3. Frame Cancer Therapeutics
  4. Genocea
  5. Gradalis, Inc.
  6. Gritstone Oncology
  7. Immunicum AB
  8. Medigene AG
  9. Ziopharm Oncology, Inc.
  10. Moderna, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports